| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.098 | 0.02 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.15 | 0.02 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.091 | 0.03 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.092 | 0.03 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |